Follow-up of Patients After Knee Arthrodesis With an Intramedullary Nail

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00284297
First received: January 30, 2006
Last updated: January 29, 2013
Last verified: January 2013
  Purpose

Follow-up of patients who underwent a knee arthrodesis with different types of intramedullary nails.


Condition Intervention
Knee Arthrodesis With Intramedullary Nail
Procedure: History taken and clinical examination

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Follow-up of Patients After Knee Arthrodesis With an Intramedullary Nail

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Follow-up of patients who underwent a knee arthrodesis with different types of intramedullary nails [ Time Frame: t0 ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 20
Study Start Date: September 2005
Estimated Study Completion Date: July 2013
Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: knee arthrodesis Procedure: History taken and clinical examination
History is taken and clinical examination is followed

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients who underwent a knee arthrodesis with an intramedullary nail between 1994 and 2005

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00284297

Contacts
Contact: René Verdonk, MD, PhD + 32 9 332.22.48 rene.verdonk@ugent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Contact: René Verdonk, MD, PhD    + 32 9 332.22.48    rene.verdonk@ugent.be   
Principal Investigator: René Verdonk, MD, PhD         
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: René Verdonk, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00284297     History of Changes
Other Study ID Numbers: 2005/213
Study First Received: January 30, 2006
Last Updated: January 29, 2013
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on July 31, 2014